May 27, 2022 Comments Off on New patent for Novartis drug KISQALI Posted in: Patent Added Annual Drug Patent Expirations for KISQALI Kisqali is a drug marketed by Novartis and is included in two NDAs. It is available from one supplier. There are eight patents protecting…
The post New patent for Novartis drug KISQALI appeared first on DrugPa…
May 27, 2022 Comments Off on New patent for Kadmon Pharms drug REZUROCK Posted in: Patent Added Annual Drug Patent Expirations for REZUROCK Rezurock is a drug marketed by Kadmon Pharms Llc and is included in one NDA. There are four patents protecting this drug. This drug…
The post New patent for Kadmon Pharms drug REZUROCK appeared first on DrugP…
